Problems Associated With Ultramarathon (CHAMONIX2)

Acute and Chronic Problems Associated With the Practice of Mountain Ultramarathon

Acute physiological consequences of ultramarathon running are still unknown, particularly in women. Results from the investigators first studies conducted in 2009 have shown that a large part of fatigue induced by a mountain ultramarathon could be attributed to central fatigue. The investigators have investigated the biological consequences and neuromuscular fatigue only in male runners. Data from the literature suggest that amplitude and etiology of fatigue after prolonged exercise might be gender-dependant.The main purpose of the present project is thus to quantify supraspinal central fatigue and associated changes in cortical excitability after an extreme exercise such as a mountain ultramarathon: the Ultra-Trail du Mont-blanc, by using TMS.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Acute physiological consequences of ultramarathon running are still unknown, particularly in women. Results from our first studies conducted in 2009 have shown that a large part of fatigue induced by a mountain ultramarathon could be attributed to central fatigue. Indeed, during extreme exercises such as 24h running, strength losses of knee extensor muscles have reached -40% and ¾ of this fatigue was explain by a central deficit while peripheral mechanisms explained only ¼. Similar results have been reported after a mountain ultramarathon despite the fact that several downhill have induced number of eccentric contractions. As a consequence, central fatigue must be particularly investigated. For this purpose, transcranial magnetic stimulation (TMS) has been recently validated to measure supraspinal central fatigue and cortical excitability.

We have investigated the biological consequences and neuromuscular fatigue only in male runners. Data from the literature suggest that amplitude and etiology of fatigue after prolonged exercise might be gender-dependant. However, these physiological data and studies that have paired male and female by level of performance on shorter distances seem contradictory with performance comparison between genders so that the relative superiority of women in ultra-endurance is not ascertained. The hypothesis of a greater fatigue resistance after ultramarathons in women should then be tested. The biological consequences of ultramarathon are far to be negligible in terms of inflammatory syndrome but complete characterization of this syndrome after such an extreme exercise has yet to be done. Also, several cases of renal failure have been reported after ultramarathons. Evaluation of ultramarathon consequences on kidneys is necessary to prevent serious complications. Finally, consequences of an ultramarathon are not only linked to races but also to training, i.e. the prolonged time spent in running to prepare for the races. Energy expenditure can be more than twice the normal one and repeated impact may potentially alter bone metabolism but to the best of our knowledge, there is no study that have assessed the effects of ultra-endurance running on bone tissue, particularly in males.

The main purpose of the present project is thus to quantify supraspinal central fatigue and associated changes in cortical excitability after an extreme exercise such as a mountain ultramarathon: the Ultra-Trail du Mont-blanc, by using TMS. The secondary purpose are (i) to compare neuromuscular and biological alterations induced by a mountain ultramarathon between males and females matched by age and level of performance, (ii) to evaluate, by biological urine and blood samples, the consequences of a mountain ultramarathon on kidneys and (iii) to investigate the hormonal status and bone mineral density of a group of male and female runners who take part to this type of event regularly.

Study Type

Observational

Enrollment (Actual)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-etienne, France, 42000
        • CHU de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

ultramarathon runner

Description

Inclusion Criteria:

  • participating to Mont-Blanc ultramarathon
  • participation in at least two ultra-endurance races like Trail

Exclusion Criteria:

  • injury within 3 months before the race
  • joint pathology
  • contra indication for magnetic stimulation transcranial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ultramarathon runner
People who do the Mont Blanc ultramarathon (31/08/12 to 02/09/12)
  • blood samples before and after ultramarathon
  • urinary samples before and after ultramarathon
  • voluntary ant electrically muscular forces measuring before and after ultramarathon
  • Broadband ultrasound Attenuation before and after ultramarathon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
central fatigue
Time Frame: Immediatly after the Mont Blanc ultramarathon
quantify supraspinal central fatigue
Immediatly after the Mont Blanc ultramarathon

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neuromuscular and biological alterations
Time Frame: Immediatly after the Mont Blanc ultramarathon
compare neuromuscular and biological alterations induced by a mountain ultramarathon between males and females matched by age and level of performance
Immediatly after the Mont Blanc ultramarathon
kidney consequences
Time Frame: Immediatly after the Mont Blanc ultramarathon
Evaluate, by biological urine and blood samples, the consequences of a mountain ultramarathon on kidneys
Immediatly after the Mont Blanc ultramarathon
hormonal status and bone mineral density
Time Frame: Immediatly after the Mont Blanc ultramarathon
investigate the hormonal status and bone mineral density of a group of male and female runners who take part to this type of event regularly
Immediatly after the Mont Blanc ultramarathon

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Leonard FEASSON, MD, Chu Saint-Etienne
  • Study Chair: Guillaume MILLET, PhD, Université de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

September 1, 2012

Study Completion (Actual)

September 1, 2012

Study Registration Dates

First Submitted

May 2, 2012

First Submitted That Met QC Criteria

May 16, 2012

First Posted (Estimate)

May 18, 2012

Study Record Updates

Last Update Posted (Estimate)

November 12, 2012

Last Update Submitted That Met QC Criteria

November 9, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 1208048
  • 2012-A00424-39 (Other Identifier: AFSSAPS)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ultramarathon Runner

Clinical Trials on ultramarathon running

Subscribe